Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

Trial Profile

Study to Evaluate the Immunogenicity and Safety of Hantavax in Healthy Adult

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 07 Jul 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Hantaan virus vaccine-(Hantavax) (Primary) ; Hantaan virus vaccine-(Hantavax) (Primary)
  • Indications Hantaan virus infections
  • Focus Pharmacodynamics; Registrational
  • Sponsors GC Biopharma
  • Most Recent Events

    • 29 Oct 2020 Results evaluating the immunogenicity and safety of Hantavax when administered by the revised 3 + 1 vaccination schedule published in the Vaccine
    • 01 Feb 2016 Status changed from not yet recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
    • 23 Sep 2015 New trial record
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top